H
business
H
HOYONEWS
HomeBusinessTechnologySportPolitics
Others
  • Food
  • Culture
  • Society
Contact
Home
Business
Technology
Sport
Politics

Food

Culture

Society

Contact
Facebook page
H
HOYONEWS

Company

business
technology
sport
politics
food
culture
society

CONTACT

EMAILmukum.sherma@gmail.com
© 2025 Hoyonews™. All Rights Reserved.
Facebook page

If AstraZeneca goes to the US, it will be a major blow for London and Labour

about 16 hours ago
A picture


Three years ago Pascal Soriot received the ultimate accolade for turning around AstraZeneca – a knighthood for services to UK life sciences and leadership in the global response to the Covid pandemic,Soriot, who fended off a takeover from the US predator Pfizer in 2014, has grown AstraZeneca into Britain’s most valuable company, thanks to an astute eye for promising medicines and developing one of the first Covid vaccines,Now the 66-year-old trained equine vet is looking at his own US adventure,He has reportedly discussed moving AstraZeneca’s stock market listing, and perhaps even its corporate base, to the US,The company declined to comment on the bombshell report, but it sent shockwaves through Britain’s scientific community.

It also threatens to topple a key pillar of the government’s fledgling industrial strategy and deprive the London market of its biggest star.The FTSE 100 company’s share price rose by 2.8% on Tuesday, with most of the gains coming after the news, but dipped by 0.1% on Wednesday, giving the company a value of nearly £161bn, ahead of Shell at £154bn.Soriot, the UK’s best-paid chief executive of a listed company, has made no secret of his growing frustration with the UK authorities in recent months.

AstraZeneca’s breast cancer drug Enhertu has not been approved for use on the NHS in England and Wales even though the company offered a low price, he claimed,The medication is available in Scotland and most other European countries,Another flashpoint came in late January, when the pharma group ditched its planned £450m investment to turn its factory in Speke near Liverpool into a major vaccine hub after failing to to agree with ministers on the size of state support,But Soriot’s – and other pharma bosses’ – biggest gripes are with the wider regulatory and commercial environment in the UK and the rest of Europe,They have called for more healthcare spending and a single list price for medicines across Europe, similar to the US, plus discounts for specific countries linked to their GDP and wealth.

The UK’s spending on new medicines does not compare well internationally, as Soriot has noted – amounting to 7% of healthcare costs versus 10 to 11% in many other European countries and 13 to 15% in the US,It also takes much longer to run a clinical trial,“Companies will go where they feel welcome because access to our medicines is good, innovation is rewarded,And of course, tax policies also play a role in all those decisions,” he has said,Otherwise, well-paid advanced manufacturing and research jobs could move to the US in the long run, he said in April.

Soriot, who grew up in the Parisian banlieues, has reiterated the company’s commitment to the UK.It has poured more than £1bn into a new global headquarters and research centre in Cambridge in recent years.This was dwarfed, however, by its recent $3.5bn (£2.5bn) investment in US research and manufacturing, including turning its Kendall Square labs in Cambridge, Massachusetts, into a state-of-the art research hub – a wise move before Donald Trump’s threatened tariffs on the pharmaceutical sector.

The suggestion that AstraZeneca could up sticks comes at difficult time for Keir Starmer’s government, which is on the back foot on many fronts,Just this week, it had to postpone publication of its long-awaited life sciences strategy because negotiations between ministers and the pharmaceutical industry about drug pricing have stalled,The 10-year plan will be coming shortly, according to the Department for Science, Innovation andTechnology,Sign up to Business TodayGet set for the working day – we'll point you to all the business news and analysis you need every morningafter newsletter promotionWhether Soriot is seriously considering a move stateside, and manages to win over the board and shareholders, is unclear,But “the mere talk of the biggest listed company leaving London will get ministers sitting up and listening”, said the Hargreaves Lansdown analyst Susannah Streeter.

The chancellor’s Mansion House speech later this month, when Rachel Reeves is expected to outline ways to revitalise London as a financial hub, will be closely watched for evidence of concrete plans to increase liquidity and make it easier for firms to list.“At a time when the government and regulators are laying out plans to make the City more attractive, if this move being mulled by AstraZeneca were to become a reality, it would be another big setback for London,” said Streeter.“The more company boards are reported to be discussing such a strategy, the more likely it will be that other firms will embark on similar discussions to assess whether moving main listings could help boost valuations.”It would be the biggest blow yet to the London Stock Exchange, which has lost a string of big names in recent months.Streeter said losing such a big player on the London market would make it even harder to lure more firms to list on the LSE.

For Labour’s creaking government, it is a headache ministers could do without.
businessSee all
A picture

UK watchdog threatens Ticketmaster with legal action over way Oasis tickets were sold

The UK competition watchdog has written to Ticketmaster threatening legal action over the way it sold more than 900,000 tickets for Oasis’s reunion tour, days before the start of what is expected to be the most popular, and profitable, run of gigs in British history.In March, the Competition and Markets Authority (CMA) published concerns that Ticketmaster may have misled fans, some of whom paid more than £350 for tickets with a face value of £150, in the way it priced tickets for the band’s comeback gigs when they went on sale last August.In response, Ticketmaster said it had made changes to “some aspects” of its ticket sales process. However, the CMA said that they were not sufficient to address its concerns.The CMA told Ticketmaster the voluntary undertakings it would accept to address its concerns

about 16 hours ago
A picture

A first-class service by Royal Mail again | Brief letters

Following my letter (23 June) complimenting the Royal Mail on delivering a letter from another reader to me with no house number, street or postcode, this week I received another addressed in exactly the same way from Peggy, who writes “Just checking whether Royal Mail can do it twice. Maybe first time was a fluke.” Evidently not. Perhaps it’s my fame as a beyond-“genius” Word Wheel player that’s helped locate me?Kevin WardQuorn, Leicestershire “What would British culture be like if Oasis had never existed?”, asks Dorian Lynskey (theguardian.com, 1 July)

about 16 hours ago
A picture

UK financial watchdog expands bullying rules to 37,000 City firms

The UK’s financial watchdog is expanding bullying and harassment rules to more than 37,000 City firms, in an effort to crack down on “rolling bad apples” who avoid consequences by hopping from firm to firm.It means that “serious, substantiated cases of poor personal behaviour” by senior managers at a range of firms including hedge funds, insurers and pension firms will have to be reported to the Financial Conduct Authority (FCA), as well as future employers who are assessing whether new hires are fit and proper for the job.Previously, only banks were required to report bad behaviour to the watchdog. The rules will now apply to tens of thousands of other firms across the City that are bound by the so-called senior managers and certification regime (SM&CR) that is meant to hold senior bosses accountable for wrongdoing at their firms.The regulator said the expanded rules would help “prevent ‘rolling bad apples’ – people moving from firm to firm without appropriate action being taken or without past serious non-financial misconduct being disclosed”

about 16 hours ago
A picture

If AstraZeneca goes to the US, it will be a major blow for London and Labour

Three years ago Pascal Soriot received the ultimate accolade for turning around AstraZeneca – a knighthood for services to UK life sciences and leadership in the global response to the Covid pandemic.Soriot, who fended off a takeover from the US predator Pfizer in 2014, has grown AstraZeneca into Britain’s most valuable company, thanks to an astute eye for promising medicines and developing one of the first Covid vaccines.Now the 66-year-old trained equine vet is looking at his own US adventure. He has reportedly discussed moving AstraZeneca’s stock market listing, and perhaps even its corporate base, to the US.The company declined to comment on the bombshell report, but it sent shockwaves through Britain’s scientific community

about 16 hours ago
A picture

Santander takeover of TSB is boost to Reeves as she fights to keep City’s trust

Santander’s takeover of TSB will be music to Rachel Reeves’ ears: sparing the under-pressure chancellor the potential embarrassment of having to explain why a major high street lender had given up on Britain.On Tuesday night, Spanish-owned Santander said it would buy TSB from its fellow Spanish owner, Sabadell, for £2.65bn, ending months of speculation over the future of the British bank – and reaffirming Santander’s commitment to the UK.Rumours had emerged in January that Santander UK could pull out of high street banking, potentially reversing gains made in stepping up its British presence with the acquisition of Abbey National two decades earlier. Bosses had started slashing 2,000 jobs months earlier, fuelling speculation that it was trying to create a leaner business that could lure potential suitors

about 16 hours ago
A picture

UK bond yields rise sharply amid speculation over future of Rachel Reeves

UK government borrowing costs have risen sharply amid speculation over Rachel Reeves’s position as chancellor, as City investors warned Labour’s welfare U-turn had blown a multibillion-pound hole in the public finances.After Keir Starmer failed initially to give his full backing to a tearful chancellor at prime minister’s questions on Wednesday, the yield on 10-year UK government bonds, also known as gilts, was on course for the biggest jump in a day since Liz Truss was in No 10, while the pound slumped.The yield – in effect the interest rate – rose by as much as 0.2 percentage points to trade close to 4.7%, climbing by the most in one day since October 2022 when investor confidence in Britain remained shaken after Truss’s mini budget

about 16 hours ago
foodSee all
A picture

Frittata, ‘egg and chips’ and a bean feast: Sami Tamimi’s brunch recipes from Palestine

1 day ago
A picture

Jam tarts and summer pudding cake: Nicola Lamb’s recipes for baking with mixed berries

1 day ago
A picture

Georgina Hayden’s recipe for spiced crab egg fried rice

2 days ago
A picture

Rukmini Iyer’s quick and easy recipe for courgette linguine with trout, lemon and dill | Quick and easy

3 days ago
A picture

Bangkok Diners Club, Manchester M4: ‘This will soon be one of Manchester’s hottest dining tickets’ – restaurant review | Grace Dent on restaurants

4 days ago
A picture

How to make coffee and walnut cake – recipe | Felicity Cloake's Masterclass

5 days ago